Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
JVSPAC Acquisition | JVSAU | 24. dec 2024 | 10.66 | 0.00 |
JX Luxventure | JXJT | 24. dec 2024 | 0.81 | 0.00 |
Kadant | KAI | 24. dec 2024 | 354.03 | +1.46 |
Kairos Pharma | KAPA | 24. dec 2024 | 1.70 | -0.87 |
Kairous Acquisition | KACL | 24. dec 2024 | 12.33 | 0.00 |
Kaiser Aluminium | KALU | 24. dec 2024 | 70.39 | +0.43 |
Kaival Brands Innovations Group | KAVL | 24. dec 2024 | 0.83 | +0.85 |
Kaixin Holdings | KXIN | 24. dec 2024 | 1.48 | -5.73 |
Kala Bio | KALA | 24. dec 2024 | 6.24 | +4.00 |
Kaltura | KLTR | 24. dec 2024 | 2.33 | -0.85 |
KalVista Pharmaceuticals | KALV | 24. dec 2024 | 8.76 | -0.79 |
Kamada | KMDA | 24. dec 2024 | 6.05 | 0.00 |
Kandi Technologies Group | KNDI | 24. dec 2024 | 0.95 | +2.74 |
Kanzhun ADR | BZ | 24. dec 2024 | 13.79 | +0.36 |
Karat Packaging | KRT | 24. dec 2024 | 30.22 | +0.13 |
Karooooo | KARO | 24. dec 2024 | 47.29 | +2.12 |
Kartoon Studios | TOON | 24. dec 2024 | 0.62 | +5.68 |
Karyopharm Therapeutics | KPTI | 24. dec 2024 | 0.59 | -3.44 |
Katapult | KPLT | 24. dec 2024 | 5.16 | -7.69 |
Kayne Anderson BDC | KBDC | 24. dec 2024 | 16.58 | 0.00 |
Kayne Anderson Energy Infrastructure Fund | KYN | 24. dec 2024 | 12.46 | +1.55 |
Kazia Therapeutics ADR | KZIA | 24. dec 2024 | 2.91 | -2.02 |
KB Financial Group ADR | KB | 24. dec 2024 | 59.55 | -0.05 |
KB Home | KBH | 24. dec 2024 | 66.40 | +0.76 |
KBR | KBR | 24. dec 2024 | 57.23 | -0.31 |
KBW Bank Powershares | KBWB | 24. dec 2024 | 66.18 | +1.27 |
KBW High Div Yield Financial Powershares | KBWD | 24. dec 2024 | 14.71 | +0.96 |
KBW Prem Yield Equity REIT Powershares | KBWY | 24. dec 2024 | 18.10 | +1.12 |
KBW Prop & Casuality Insur Powershares | KBWP | 24. dec 2024 | 116.43 | +0.80 |
KBW Regional Banking Powershares | KBWR | 24. dec 2024 | 60.50 | +0.82 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.